Board of Directors & Board committees

Michael Wolff Jensen
Chairman
Board member as well as chairman since 2013
Chairman of the Remuneration Committee
Born 1971
Education: Master of Laws (LL.M.), University of Copenhagen
Other current activities: Other current activities: Chairman of the Board in Ascendis Pharma A/S, Vicore Pharma AB and VISEN Pharmaceuticals Ltd, Chairman of the Board as well as owner of MIWO Invest ApS (former MWJ Partners ApS), board member of Xspray Pharma Futurum AB
Other board assignments (the recent 5 years): Chairman of the Board in Eurocines Vaccines AB and VANX ApS
Holdings: 25,000 shares through MIWO Invest ApS (former MWJ Partners ApS)
Independent in relation to the Company and its management and in relation to major shareholders

Maris Hartmanis
Board member
Board member since 2015
Chairman of the Audit Committee
Born 1953
Education: Dr. of Technology and Associate Professor, Royal Institute of Technology
Other current activities: Other current activities: CEO and Chairman of the Board in Hartmanis & Partners AB as well as board member in BioLamina, CEO and Chairman of the foundation FINGERS Brain Health Institute
Other board assignments (the recent 5 years): Board member in Xbrane Biopharma AB, karolinska Institutet Holding AB and Applied Photophysics Ltd., England, and vice Chairman of the Board in ProNova, a VINNOVA Center of Excellence for protein technology at Kungliga Tekniska Högskolan
Holdings: 28,619 shares
Independent in relation to the Company and its management and in relation to major shareholders

Carl-Johan Spak
Board member
Board member since 2015
Member of the Audit Committee
Born 1956
Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institutet
Other current activities: Other current assignment: Board member of Atrogi AB, Empros Pharma AB, Follicum AB, Inject Pharma Sweden AB, KAHR Medical Ltd., Pharmacolog in Uppsala AB (publ), Prokarium Ltd., SwedenBIO Service AB, Binx Helth Ltd, UK and Symcel AB, member of board as well as CEO of Recipharm Venture Fund AB and deputy in Buzzard Pharmaceuticals AB
Other board assignments (the recent 5 years): Chairman of the board in Bostadsrättsföreningen Smultronhyllan, Cobra Biologics Matfors AB, Cobra Biopharma Matfors AB, Cobra Biologics Holding AB,
Recipharm OT Chemistry AB and Recipharm Pharmaceutical Development AB. Member of the board in Synthonics, Inc., Pharmanest
AB, Recipharm OT Chemistry AB och Recipharm Strängnäs AB and deputy member of the board in Cobra Biologics AB och Cormorant
Pharmaceuticals AB
Holdings: None
Independent in relation to the Company and its management and in relation to major shareholders

Torbjörn Koivisto
Board member
Board member since 2017
Member of the Remuneration Committee
Born 1969
Education: Master of Laws (LL.M.), University of Uppsala
Other current activities: Other current activities: Board member of Hemcheck Sweden AB, Cinclus Pharma Holding AB and IARU Institutet för Affärsjuridisk Rådgivning I Uppsala AB, partner in KOL Arts & Craft Handelsbolag as well as deputy of RJC Roger Johansson Consulting AB
Holdings: 4,000 shares via company (IARU)
Independent in relation to the Company and its management and in relation to major shareholders

Christine Lind
Board member
Board member since 2019
Member of the Audit Committee
Born 1974
Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School
Other current activities: Other current activities: Chairman and CEO of Lind Growth Strategy AB, member of the board in Immunicum AB and deputy board member of Shinka Life Sciences AB
Other board assignments (the recent 5 years): CEO of Medivir AB
Holdings: 4,000 shares
Independent in relation to the Company and its management and in relation to major shareholders

Gunnar Gårdemyr
Board member
Board member since 2019
Member of the Remuneration Committee
Born 1959
Education: BSc Economy, University of Lund
Other current activities: Other current assignments: Chairman of the Board in Rhovac AB, member of the Board in Iconovo AB and Asgard Therapeutics
Other board assignments (the recent 5 years): CEO Targovax AS, Norge, CBO in Follicum AB
Holdings: 4,400 shares
Independent in relation to the Company and its management and in relation to major shareholders
Board committees
Audit Committee
- Maris Hartmanis, Chairman
- Christine Lind
- Carl-Johan Spak
Renumeration committee
- Michael Wolff Jensen, Chairman
- Gunnar Gårdemyr
- Torbjörn Koivisto